Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02768805Phase 2Completed
Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults
Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more
Principalinvestigator
NCT02831751Phase 2Completed
Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults
Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more
Principalinvestigator

Research Network

Collaboration Network

19 collaborators·52 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Regional Clinical Research (RCR), Endwell (NY), USA

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Trevor Wesson, MD

Diex Research Montreal, Montreal, Canada

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 2 trials
Similarity Score48%

Deepen Patel, MD

Topstone Research, Toronto, Canada

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 2 trials
Similarity Score48%

Michael Libman, MD

McGill University Health Center - Vaccine Study Center (MUHC), Montreal, Canada

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 2 trials
Similarity Score48%

Ginette Girard, MD

Diex Research Sherbrooke, Sherbrooke, Canada

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 2 trials
Similarity Score48%

Pierre Lachance, MD

Centre de Recherche St-Louis, Quebec, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Brandon J Essink, MD

Meridian Clinical Research, Omaha (NE), USA

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Guy Tellier, MD

Omnispec Clinical Research Inc, Mirabel, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Gérald Vallières, MD

Manna Research, Lévis, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Paul Bradley, MD

Meridian Clinical Research, Savannah (GA), USA

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Pierre Lachance, MD

Centre de Recherche St-Louis, Quebec, Quebec, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02768805Phase 2PrincipalInvestigator

Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more
Completed
NCT02831751Phase 2PrincipalInvestigator

Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more
Completed

All 2 trials loaded